A groundbreaking study published in the journal Neurology has found that a new migraine prevention drug, Atogepant, provides immediate relief to people suffering from migraines. The study, which was conducted over 12 weeks and involved three trials, showed that individuals taking Atogepant were less likely to experience migraines on the first day of treatment compared to those on a placebo.
The research found that Atogepant reduced the likelihood of migraines by 61% in one trial, 47% in another, and 37% in the third. Participants on Atogepant also experienced fewer migraine days each week, with an average decrease of one day per week compared to those on a placebo.
The study’s author, Dr. Richard B. Lipton, stated that current treatments often take weeks or months to become effective and can have side effects. Developing a medication that works quickly and effectively is critical for people living with migraines.
Atogepant was tested in individuals with episodic and chronic migraines. The study found that Atogepant improved the overall quality of life for those taking it, particularly when compared to those on a placebo.
Migraine is a debilitating condition characterized by headaches, nausea, fatigue, vision changes, and more. It affects millions worldwide, causing significant disability and impacting daily life. The exact cause of migraines is still unknown, but research suggests that abnormal activity in nerve signals, chemical signals, and blood vessels in the brain may contribute to their development.
A common migraine trigger is hormonal changes, such as the start of a menstrual cycle. Other triggers can include stress, sensory stimuli, and certain foods. Symptoms can vary from person to person, but often include intense headaches, nausea, and sensitivity to light and sound.
The study’s findings offer hope for people living with migraines. With Atogepant, individuals may experience quick relief from symptoms, improving their overall quality of life. As research continues to advance our understanding of migraines, new treatments like Atogepant may become available, providing even more effective management options for this debilitating condition.
Source: https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/groundbreaking-migraine-drug-offers-instant-relief-reduces-pain-from-day-1/articleshow/116636979.cms